“We are discussing a distinct system of action that these drugs have in comparison with the aged serotonergic compounds,” claims Vermetten “The system motion doesn't depend upon one particular molecule.”This Viewpoint examines how US states are reforming legislation to allow entry to psychedelics for therapeutic use, but federal rules take